Inovalon and MEDITECH Collaborate to Transform and Optimize Revenue Cycle
SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment ProcessesBOWIE, Md., June 28, 2024 (GLOBE NEWSWIRE) --...
News
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
CHMP adopts positive opinion for BALVERSA® (erdafitinib) for the treatment of adult patients with unresectable or metastatic urothelial carcinoma with susceptible FGFR3 genetic alterations
Pending approval, erdafitinib would become the first therapy targeting FGFR3 alterations in patients with metastatic urothelial carcinoma, one of Europe’s...
Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
Positive recommendation is based on two Phase III studies. In addition to robust retinal drying with Vabysmo, these data show...
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day
A nomination to add MLD to the U.S. Recommended Uniform Screening Panel has been submitted by a multi-disciplinary expert working...
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
Recommendation based on data from the Phase 1 and pivotal Phase 2 trials demonstrating robust and durable response rates in...
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and...
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
SEATTLE and CAMBRIDGE, United Kingdom, June 28, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today that the...
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
First of Multiple Planned Global Submissions for Lifileucel in 2024 and 2025 Key Step in Global Expansion to Address >20,000...
CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition
If approved, PiaSky will be the first monthly subcutaneous (SC) treatment for paroxysmal nocturnal haemoglobinuria (PNH) in the EU Additionally,...
Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee for Medicinal...
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF...
ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy positioned to be the first and only needle-free adrenaline option authorized for emergency treatment of allergic reactions (anaphylaxis) in...
SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women
SNIPR BIOME receives funding from the Bill & Melinda Gates Foundation to accelerate the development of SNIPR Biome's microbial gene...
Bulletin from the 2024 Annual General Meeting of PMD
STOCKHOLM, SWEDEN / ACCESSWIRE / June 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The Annual General Meeting of PMD Device...
Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody’s, and S&P Global
Reduces Waystar's cost of capital and enhances its ability to allocate free cash flow towards growth initiatives LEHI, Utah and...
NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT
HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-10...
Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology
License provides exclusive access to innovative epigenetic editors and expands the reach of Chroma's platform BOSTON, June 27, 2024 /PRNewswire/...
Pulmonary Fibrosis Foundation’s 2024 PFF Walk Raises Funds Toward a Cure
Nationwide Walk Series Kicks Off July 20 in Pittsburgh CHICAGO, June 27, 2024 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF)...
Magnolia Medical Launches New Magnolia Analytics™ Service to Streamline Data Capture and Quantify the Clinical & Cost Effectiveness of Preventing Sepsis Misdiagnosis
This unique, proprietary service is exclusively available to Magnolia Medical customers as part of its Mission to ZERO® standards change...